Weekly Report: what happened at XHE last week (0715-0719)?

ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors

Weekly Report: what happened at XHE last week (0708-0712)?

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

Q3 2024 Equity Market Outlook

Home Market Outlook Today's Market Q3 2024 Equity Market Outlook: Neuberger Berman 2.93K Followers. We expect further corporate earnings growth across sectors, fueled by rising household net worth and a global industrial rebound. We recommend overweighting technology, communications and consumer discretionary stocks.

Weekly Report: what happened at XHE last week (0701-0705)?

Earnings Preview: What to Expect From GE HealthCare’s Report

GE HealthCare Technologies Inc. (GEHC) is expected to report its fiscal Q2 earnings results on Tuesday, July 23. The company's shares have dropped 4.3% over the past 52 weeks. Analysts are expecting GEHC to report a profit of $0.97 per share.

CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened

Midyear Equity Outlook - Investing Beyond The Megacaps

Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.

Weekly Report: what happened at XHE last week (0624-0628)?

From AI To Green Metals: Strategic Investments For A Changing World

Green transition is driving this unprecedented demand for metals and minerals. By 2030, we will need 50 new lithium mines to meet the growing demand for electric vehicles (EVs) and renewable energy infrastructure. The clean appearance of EVs, solar panels, and windmills belies the dirty reality that they require lots and lots of mining.

Weekly Report: what happened at XHE last week (0617-0621)?

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Weekly Report: what happened at XHE last week (0610-0614)?

Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst

Needham & Co. Analyst Mike Matson upgraded Haemonetics Corporation from Hold to Buy with a price target of $112. The analyst says the company has reaffirmed its “high-20%” operating margin goal for FY26. Matson also says that the company's product mix analysis has bolstered his confidence.

Weekly Report: what happened at XHE last week (0603-0607)?

What The 2024 Elections Could Mean For Health Care Investors

Health care spending now accounts for 17% of the U.S. GDP. Election year volatility could mean opportunity for health care investors. The fate of medical exchanges and providers could be impacted by the election outcome. The outcome of the presidential election in 2024 could have implications for the health care sector.

Weekly Report: what happened at XHE last week (0527-0531)?

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Weekly Report: what happened at XHE last week (0520-0524)?